US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

FTC Takes Big Swing In Hims & Hers Privacy Suit No Photo Available

Yeji Jesse Lee

Healthcare experts say the FTC's privacy-focused suit against a leading telehealth company is a warning for the larger direct-to-consu... (more story)

HHS Bolsters 340B Rebate Plan After Legal Setbacks No Photo Available

Dan McKay

The Trump administration beefed up the regulatory record in its latest push to establish rebates in the 340B drug pricing program, set... (more story)

DOJ Warns Fraud Disclosures Won't Shield Culpable Execs No Photo Available

Mark Payne

A decision by justice officials to decline criminal fraud charges against an optometry practice shows the department's ongoing willing... (more story)